Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pocared’s P1000™ system provides rapid (<hours), fully automated identification and quantification of bacteria/yeast and their antimicrobial resistance markers directly from patient samples without the need for culture. The company claims this enables real-time results for clinicians to optimize infection treatment and antibiotic stewardship. As of mid–2022, the company was finalizing development with EIB funding to support clinical trial preparations. No published pivotal clinical trial results found.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pocared Diagnostics.